CD274 and thyroid gland carcinoma: Given the known therapeutic implications of PD-L1 expression in melanoma, PD-L1 mRNA levels in 6 human thyroid cancer cell lines was quantified against 3 BRAFV600E melanoma cell lines (A375, A2058 and UACC903) and one BRAFWT (MelJuso) (Figure 1).